📌 Key Takeaways
- Topic: Silicon Oxide Anode (SiOx): How It Works and Its Advantages for Lithium-Ion Batteries
- Keywords: hydrated silica
- Published: 2026-11-20 03:35:38
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Manufacturer in China: How to Evaluate Quality, Capacity and Export Experience
- Silica Aerogel Powder: Properties, Applications and How It Compares to Other Insulators
- Crystalline Silica Dust Hazard: Health Risks and How to Protect Workers
- Quartz CAS 14808-60-7: Identification, Hazards and Regulatory Information
- INS 551 Explained: Silicon Dioxide Food Additive Code, Uses and Regulations
Silica Mesh Size Chart: Mesh to Micron Conversion and How to Choose
What is silica (SiO₂)?
precipitated silica market
What is the difference between fumed silica and precipitated silica?
silica carrier Gene therapy refers to the introduction of exogenous genes into the target cells to treat diseases by replacing defective genes or adding new genes. 452, 453 In many cases, the core of gene therapy lies in the selection of a fitting gene vector to efficiently deliver the gene to the target cells. 454, 455 Viral vectors are frequently used in clinical settings, and even though they have high efficiency in gene transfection, their safety issue, i.e., causing adverse immune response in the body, cannot be ignored. 454 MSNs, as brilliant multifunctional non-viral vectors, have advantages in biocompatibility, tissue toxicity, and targeting. 456, 457 As early as 2004, MCM-41-type MSNs were used as gene transfection reagents for delivery of plasmid DNA. 52 Since then, many different gene therapy tactics have been developed based on MSNs, and their therapeutic effects have been validated in the fields of tumor therapy, 458, 459, 460 diabetes treatment, 378 and wound healing. 461, 462 As an example, suicide gene therapy as a gene-mediated enzyme prodrug treatment, is able to kill tumor cells specifically after in situ conversion of the drug into toxic drugs. 463 To control the synergistic intracellular release of suicide genes and prodrugs and enhance therapeutic efficacy, Wang et al. investigated the efficacy of spherical and rod-shaped magnetic MSNs in targeted drug delivery, and gene transfection, MRI imaging, and hepatocellular carcinoma treatment. It was demonstrated that the Janus-type rod-like magnetic MSNs loaded with ganciclovir (GCV) and functionalized by PEG-g-PLL revealed better drug-loading ability and faster drug release behavior, indicating that they are a useful tool to build the herpes simplex virus thymidine kinase/ganciclovir (HSV-TK/GCV) gene therapy system. 464
What drives silica raw material prices?
silica filler for CCL Along with targeted ligand, cell membrane-based biomimetic strategy is also a current and really feasible approach to enhance the targeting skill of MSNs (Fig. 6b ). The cell membrane biomimetic method dates back to 2011, when Zhang's group used intact red blood cell membranes to encapsulate NPs via a top-down strategy. Compared with unencapsulated NPs, NPs encapsulated by red blood cell membranes have a longer half-life in mice and remain in circulation for up to 72 h due to the immune escape function possessed by the cell membrane. 326 The preparation process is typically divided into three steps: membrane extraction, preparation of inner core NPs, and fusion of membrane and NPs. The cell membrane-coated NPs combine the benefits of outer cells and inner core NPs, and achieve long-term in vivo circulation and targeted delivery while greatly improving biocompatibility. 327 The therapeutic potential of diverse types of cell membranes-engineered MSNs-based drug delivery systems has been demonstrated in a variety of disease models. For example, platelet membrane-coated MSNs were used for early atherosclerosis therapy by mimicking the immune escape ability of platelet. 328 Cancer cell membrane-coated MSNs were specifically enriched in tumor sites by homologous targeting properties, and activated the ferroptosis-related immunogenic cell death on gastric cancer. 329 Bacterial outer membrane-coated MSNs are used for targeted delivery of the antibiotic rifampicin to achieve in vivo resistance to gram-negative bacterial infections. 330 Despite the limitations of current research related to cell membrane biomimetic tactic, these instances invariably show the effectiveness of cell membrane-based active targeting strategy in enhancing the targeting ability and therapeutic efficacy of MSNs.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.